Huaxing Growth Capital hits first close of latest USD fund at nearly $550m, targets $1.2b

Huaxing Growth Capital hits first close of latest USD fund at nearly $550m, targets $1.2b

Mr. Fan Bao, Founder, Chairman, Executive Director and Chief Executive Officer of China Renaissance (left) and Mr. Kevin XIE, Co-founder & Head of Healthcare Advisory hitting the Gong at the listing ceremony

Huaxing Growth Capital, the flagship fund of investment bank China Renaissance, has held the first close for its fourth US dollar-denominated fund at nearly $550 million. The firm seeks to raise $1.2 billion for the vehicle.